全文获取类型
收费全文 | 387997篇 |
免费 | 28316篇 |
国内免费 | 9617篇 |
专业分类
耳鼻咽喉 | 4257篇 |
儿科学 | 9936篇 |
妇产科学 | 6977篇 |
基础医学 | 29506篇 |
口腔科学 | 8574篇 |
临床医学 | 43118篇 |
内科学 | 45832篇 |
皮肤病学 | 5043篇 |
神经病学 | 20025篇 |
特种医学 | 9017篇 |
外国民族医学 | 34篇 |
外科学 | 38713篇 |
综合类 | 62676篇 |
现状与发展 | 22篇 |
一般理论 | 52篇 |
预防医学 | 38754篇 |
眼科学 | 5546篇 |
药学 | 35561篇 |
615篇 | |
中国医学 | 46972篇 |
肿瘤学 | 14700篇 |
出版年
2024年 | 1454篇 |
2023年 | 6710篇 |
2022年 | 11807篇 |
2021年 | 15926篇 |
2020年 | 15176篇 |
2019年 | 19977篇 |
2018年 | 17524篇 |
2017年 | 14951篇 |
2016年 | 12434篇 |
2015年 | 11581篇 |
2014年 | 24482篇 |
2013年 | 25180篇 |
2012年 | 22174篇 |
2011年 | 23798篇 |
2010年 | 19195篇 |
2009年 | 17052篇 |
2008年 | 16252篇 |
2007年 | 16748篇 |
2006年 | 14456篇 |
2005年 | 12468篇 |
2004年 | 10107篇 |
2003年 | 8843篇 |
2002年 | 6885篇 |
2001年 | 6204篇 |
2000年 | 5148篇 |
1999年 | 4401篇 |
1998年 | 3564篇 |
1997年 | 3390篇 |
1996年 | 2866篇 |
1995年 | 2754篇 |
1994年 | 2644篇 |
1993年 | 2085篇 |
1992年 | 2099篇 |
1991年 | 1829篇 |
1990年 | 1618篇 |
1989年 | 1428篇 |
1988年 | 1350篇 |
1985年 | 3820篇 |
1984年 | 4827篇 |
1983年 | 3354篇 |
1982年 | 3821篇 |
1981年 | 3572篇 |
1980年 | 3180篇 |
1979年 | 2912篇 |
1978年 | 2540篇 |
1977年 | 1914篇 |
1976年 | 2154篇 |
1975年 | 1635篇 |
1974年 | 1432篇 |
1973年 | 1278篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
胆囊切除术是公认的胆囊良性疾病的治愈手段,国内外学术界对于手术适应证和手术时机已有明确共识。近年来,“保胆手术”治疗胆囊良性疾病颇受热议,一些医生将“保护胆囊”的学术观点等同于“保留胆囊”的手术技术,这种误解可能导致病人出现差异性的预后。因此,临床医师应明晰“保护胆囊”理念与“保胆手术”的差别,对胆囊良性疾病的诊疗原则有正确的理解和应用。 相似文献
23.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
24.
25.
《Annales médico-psychologiques》2021,179(8):744-747
The teaching and clinical practice of professor Yves Pélicier contributed to the international development of a psychiatry centered on the whole of the person in a humanist approach. The theoretical developments were marked by the authenticity of the practice of the therapist and its deep sense of the human being thus truly founding a School. 相似文献
26.
《Clinical neurophysiology》2021,132(9):2003-2011
ObjectiveA large N20 and P25 of the median nerve somatosensory evoked potential (SEP) predicts short survival in amyotrophic lateral sclerosis (ALS). We investigated whether high frequency oscillations (HFOs) over N20 are enlarged and associated with survival in ALS.MethodsA total of 145 patients with ALS and 57 healthy subjects were studied. We recorded the median nerve SEP and measured the onset-to-peak amplitude of N20 (N20o-p), and peak-to-peak amplitude between N20 and P25 (N20p-P25p). We obtained early and late HFO potentials by filtering SEP between 500 and 1 kHz, and measured the peak-to-peak amplitude. We followed up patients until endpoints (death or tracheostomy) and analyzed the relationship between SEP or HFO amplitudes and survival using a Cox analysis.ResultsPatients showed larger N20o-p, N20p-P25p, and early and late HFO amplitudes than the control values. N20p-P25p was associated with survival periods (p = 0.0004), while early and late HFO amplitudes showed no significant association with survival (p = 0.4307, and p = 0.6858, respectively).ConclusionsThe HFO amplitude in ALS is increased, but does not predict survival.SignificanceThe enlarged HFOs in ALS might be a compensatory phenomenon to the hyperexcitability of the sensory cortex pyramidal neurons. 相似文献
27.
28.
29.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
30.